clarithromycin has been researched along with Leishmaniasis, Cutaneous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi Shaye, Z; Ghanizadeh, S; Layegh, P; Salehi, M; Zabolinejad, N | 1 |
| Benchikhi, H; Hali, F; Khadir, K; Marouane, S; Ouakadi, A; Radouane, N; Soussi, M; Zamiati, S | 1 |
2 other study(ies) available for clarithromycin and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime.
Topics: Antiprotozoal Agents; Clarithromycin; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2022 |
[Generalized chromomycosis caused by Phialophora verrucosa].
Topics: Adult; Amphotericin B; Antifungal Agents; Arm; Chromoblastomycosis; Clarithromycin; Diabetes Complications; Diagnosis, Differential; Female; Hand Dermatoses; Humans; Itraconazole; Leishmaniasis, Cutaneous; Morocco; Naphthalenes; Phialophora; Terbinafine; Tuberculosis, Cutaneous | 2013 |